Best High Tech Stocks To Buy For 2019

One thing that investors new to the stock market often don’t look at is a company’s market capitalization, which is the “total market value of a company’s outstanding shares of stock.” This is a much more meaningful metric than, say, stock price, because it tells you how the market values the business. 

If, as an investor, you think that a company’s business could (or should) be worth more than its current market capitalization, then the shares could represent a buying opportunity. Conversely, if a company’s market capitalization seems too high relative to its business opportunities, then it could mean that it’s time to sell the stock.

Image source: Apple.

Apple (NASDAQ:AAPL), arguably the most innovative technology company in the world, is on its way to commanding a market capitalization of $1 trillion, which would make it the first publicly traded company to ever achieve that market value. Assuming a diluted share count of around 5.07 billion (note that Apple has been aggressively buying back stock so this number comes down a lot each quarter), Apple will hit a $1 trillion market capitalization when the stock hits approximately $197.23 per share.

Best High Tech Stocks To Buy For 2019: Capella Education Company(CPLA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Capella Education (NASDAQ:CPLA) reached a new 52-week high on Monday . The stock traded as high as $104.10 and last traded at $103.20, with a volume of 487 shares trading hands. The stock had previously closed at $103.70.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Capella Education (CPLA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best High Tech Stocks To Buy For 2019: Noodles & Company(NDLS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Motley Fool Transcribing]

    Noodles & Co. (NASDAQ:NDLS) Q2 2018 Earnings Conference CallJul. 18, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Noodles & Co (NDLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Noodles & Company (NASDAQ:NDLS) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 10th. Analysts expect Noodles & Company to post earnings of ($0.03) per share for the quarter. Noodles & Company has set its FY18 guidance at $(0.01)-0.03 EPS.

  • [By Max Byerly]

    Noodles & Co (NASDAQ:NDLS) had its price target lifted by equities research analysts at Citigroup from $11.50 to $15.00 in a report released on Tuesday, Stock Target Advisor reports. The firm currently has a “buy” rating on the restaurant operator’s stock. Citigroup’s price objective suggests a potential upside of 18.58% from the company’s previous close.

Best High Tech Stocks To Buy For 2019: Northgate Minerals Corporation(NXG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Best High Tech Stocks To Buy For 2019: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Insulet (PODD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

  • [By Timothy Green, Nicholas Rossolillo, and Todd Campbell]

    For growth investors with a long time horizon, three of our Motley Fool contributors think Facebook (NASDAQ:FB), Cisco Systems (NASDAQ:CSCO), and Insulet (NASDAQ:PODD) are solid growth stocks worth owning. Here’s why.

  • [By Max Byerly]

    Insulet (NASDAQ: PODD) is one of 106 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Insulet to related companies based on the strength of its valuation, earnings, analyst recommendations, institutional ownership, risk, dividends and profitability.

  • [By Logan Wallace]

    Insulet Co. (NASDAQ:PODD) SVP Michael P. Spears sold 5,043 shares of the business’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $86.08, for a total value of $434,101.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Best High Tech Stocks To Buy For 2019: ProAssurance Corporation(PRA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ProChain (CURRENCY:PRA) traded up 1.1% against the US dollar during the 1 day period ending at 12:00 PM ET on September 28th. ProChain has a total market cap of $5.06 million and $110,631.00 worth of ProChain was traded on exchanges in the last day. In the last seven days, ProChain has traded down 20% against the US dollar. One ProChain token can now be bought for approximately $0.10 or 0.00001535 BTC on popular exchanges including Bit-Z, FCoin, OKEx and Bibox.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ProAssurance (PRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on ProAssurance (PRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *